CompletedNot Applicable

Detection of Heart Conditions Using Artificial Intelligence

United States68 participantsStarted 2021-06-01

Plain-language summary

The purpose of this study is to evaluate how Eko AI performs in the real world, front-line setting where the availability of sophisticated, expensive diagnostic tools is limited, and where there is a premium on detecting VHD early in its course.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * English-speaking adults who are 18 years and older * Able and willing to provide informed consent * Complete a clinical echocardiogram within 7 days before or after study procedures Exclusion Criteria: * Unwilling or unable to provide informed consent * Patients who are hospitalized

What they're measuring

Single-lead ECG based algorithm development

Timeframe: Within two minutes of device use

Single-lead ECG based algorithm Performance

Timeframe: Within two minutes of device use

Trial details

NCT IDNCT04933890

SponsorEko Devices, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Left Ventricular Dysfunction trials